Atlas Trials

Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)

Clinical trial NCT02623998 · COMPLETED

Trial details

NCT number
NCT02623998
Sponsor
Population Health Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2016-07-09
Primary completion
2018-09-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.